학술논문

Safety run-in results from LEAP-014: First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (ESCC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; NOV 2023, 34 pS1548-pS1548, 1p. Supplement: 4
Subject
Language
English
ISSN
15698041